Monthly Archives: October 2012

Protease inhibitors. Part 2

Several phase II and III studies have assessed the efficacy and safety of telaprevir in treatment naive G1 patients, concluding that triple therapy yields a higher rate of SVR than current SoC and lower rates of relapse. The SVR for … Continue reading

Posted in Other | Leave a comment